Speaker Profile
Ph.D., CEO, MyOme
Biography
Dr. Premal Shah leads MyOme's efforts to make clinical grade whole genome sequencing available to everyone. Before MyOme, Dr. Shah was President, COO and Co-Founder at Ciitizen (acquired by Invitae), where he led the company's efforts to develop the core Ciitizen technology enabling patients to seamlessly acquire and codify their personal health records from structured and unstructured data. Prior to Ciitizen, Dr. Shah was CEO of Applied Proteomics, a proteomics platform company that developed a blood-based colorectal cancer screening test. In addition, Dr. Shah has held leadership positions at Genomic Health and was a management consultant at Booz Company, serving clients throughout the healthcare ecosystem. Dr. Shah completed his graduate work at the California Institute of Technology.
Talk
Clinical Grade Whole Genome Sequencing
For the first time, a sub $500 clinical-grade whole genome is available to everyone, enabling on-going analysis throughout a patient's life, including use of polygenic risk scores for assessing risk of common diseases (e.g., CAD, T2D) that integrate a patient's clinical risk factors.
Session Abstract – PMWC 2024 Silicon Valley
Track Chair: Stacey Gabriel, Broad Institute and Steve Turner, PacBio
- New Frontiers in Genomic Analysis & Interpretation
- Robert Sebra, ISMMS
- Anshul Kundaje, Stanford
- Chaz Langelier, UCSF
- Orly Alter, Prism AI Inc - From Potential to Reality: Bringing Nanopore Sequencing to Clinical Practice (PANEL)
Chair: Emma Stanton, Oxford Nanopore Tech - Charles Chiu, UCSF
- Billy Tsz Cheong Lau, Stanford - Population Sequencing at Scale: Impact and Future Path of Genomic Programs (PANEL)
Chair: Stacey Gabriel, Broad Institute
- Heidi Rehm, MGH
- Cindy Lawley, Olink
- John M. Gaziano, Million Veterans Program (MVP) - New Frontiers in Genomic Analysis & Interpretation continues: AI in Spatial Transcriptomics in Patient Response
- David. W. Craig, City of Hope Cancer Center
- Premal Shah, MyOme - The Economic Perspective on Genomics (PANEL)
Chair: Bill Hyun, UCSF
- Steve Turner, PacBio
- Alex de Winter, Danaher Ventures
- Kandaswamy (Swamy) Vijayan, Zafrens - Using AI for Scalable Phenotyping and Discovery
- Andrew Carroll, Google
- Building Bridges: Precision Medicine Communities
- Kumar Prashant, Karkinos - NCI Showcase
- Xiaofeng Xie, MicrOmics Technologies
